News

Clinicians, researchers, and vendors in the neurotechnology field have a lot more to think about given recent news about involuntary outpatient commitment programs. One such program in New York State, known as Kendra’s Law in honor of a victim of a subway attack schizophrenia, provides intensive caseworker monitoring to ensure certain psychiatric patients obtain outpatient treatment. While most of…

The mood was upbeat at the INS meeting in Berlin earlier this month with the news of St. Jude Medical’s investment in Spinal Modulation [see article, p4, Conference Report, p7]. In an industry beset by misfortunes, from failed clinical trials to lengthy approval cycles, to tighter capital availability, any kind of good news was welcome to investors, startups, and established players alike. With one…

Save over $500 With Our Special Offer for Industry Leaders! For a limited time, you can order your copy of The Market for Neurotechnology, 2001-2005, plus your charter subscription to Neurotech Business Report for the special price of $1395,a savings of $500 off the regular price for both products. When you do so, you will not only save money, you’ll gain exclusive access to the findings and the data before your competitors do.

Neurotechnology Entrepreneur to Keynote 2005 Neurotech Leaders Forum Alan Levy, President and CEO of Northstar Neuroscience, Inc., will keynote the 2005 Neurotech Leaders Forum, to be held in San Francisco, CA October 20-21. Levy, founder of one of the most promising venture capital-backed neurotechnology firms, will address many of the issues involved with launching a neurotechnology startup. The fifth annual event, produced , will be held at the Crowne Plaza San Francisco International Airport.

Neural Prosthesis Recipient to Keynote 2003 Neurotech Leaders Forum Jennifer French, one of the first recipients of an experimental standing/transfer prosthesis that allows paraplegics to stand up using their own paralyzed leg muscles, will deliver the keynote talk at the 2003 Neurotech Leaders Forum in San Francisco. The event, a full-day management and investment conference directed at neurotechn…

Neurotechnology Pioneers and Entrepreneurs to Highlight October Investment Conference Some of the world’s leading researchers and entrepreneurs in neural prostheses, neurostimulation, and advanced brain sensing will participate in the second annual Neurotech Leaders Forum, to be held in San Francisco October 3, 2002. The full-day event offers an opportunity for researchers and executives in the neurotechnology field to interact with venture capital firms and other funding organizations.

New Publishing Firm Devoted to Neurotechnology Market Neurotech Reports, a Torrance, CA based publisher of newsletters and market research reports, has been launched to provide strategic information on the new and growing field of neurotechnology. Neurotechnology is defined as the application of electronics and engineering to human nervous system function. It is a distinct field from biotechnology, which concerns itself largely with molecular and genetic engineering approaches to human biology.

The 2013 Annual Meeting of the American Psychiatric Association, held in San Francisco earlier this month [see Conference Report, p7], was significant for several reasons. First, the association had just released the fifth edition of Diagnostic and Statistical Manual of Mental Disorders and the new version was fodder for much discussion. While there is not universal agreement among professionals wi…

Vendors and researchers in the implanted neuromodulation device field have long been familiar with the “last resort” nature of neurotechnology interventions. Because of perceived risks, surgical complications, and up-front costs associated with implanted stimulation devices, clinicians generally do not recommend neurostimulation therapy until patients have exhausted all other available interventions.

From the March 2013 issue of Neurotech Business Report © 2013 Neurotech Reports Neural engineers, clinicians, and neuroscience researchers came to Houston, TX last month for the 2013 International Workshop on Clinical Brain-Neural Machine Interfaces. The first-ever event was sponsored , the Methodist Hospital Research Institute, and The Institute for Rehabilitation and Research, with major funding from the National Institutes of Health and the National Science Foundation.